By stimulating cancer cells to produce a molecule that activates a signaling pathway in nearby immune cells, MIT researchers ...
Bizcommunity on MSN
Aspen Pharmacare reaches €25m settlement in mRNA contract dispute
Aspen Pharmacare said it had reached a €25m settlement in a contractual dispute with a client over a manufacturing and ...
By stimulating cancer cells to produce a molecule that activates a signaling pathway in nearby immune cells, MIT researchers have found a way to force tumors to trigger their own destruction.
Yale researchers have developed a new vaccine that does double duty against a rare and aggressive skin cancer by targeting ...
Demonstrated feasibility of effective DNA delivery with Company's xPhore nanoparticle technologyDNA delivery technology to be offered as GenePhore to biotech / pharma companiesAddressing large and gro ...
CREATE Medicines, Inc. (formerly Myeloid Therapeutics), a clinical-stage biotech pioneering in vivo multi-immune programming, today announced that clinical results from its Phase 1 MYE Symphony trial ...
Moderna, Inc. (NASDAQ:MRNA) today announced that the first patient has been dosed in a Phase 1/2 study of mRNA-2808, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback